Journal of Surgical Oncology · 2020 · 70 citations · 38 references
MedicineOrthopaedic SurgerySurgeryOncologic SurgeryOrthopedicsReconstructive SurgeryBone Defect ReconstructionBone Tumor SurgeryJoint SurgeryReconstruction After Tumor ResectionReconstructive Orthopedic SurgeryThree-dimensional Reconstruction3D-printed Surgical GuidesFunctional Outcomes After ReconstructionFunctional Outcomes After SurgeryIntercalary ReconstructionLocal Tumor RecurrenceMetaphyseal Bone DefectsThree-dimensional Printing For ReconstructionThree-dimensional Printing Of Prostheses
BACKGROUND: Joint-preserving intercalary tumor resection can result in better proprioception and a more normal joint function after reconstruction. However, most reported reconstruction techniques are usually associated with frequent complications. Therefore, the approach of reconstruction following joint-preserving tumor resection warrants further study. METHODS: Between September 2016 and October 2018, 12 patients with metaphyseal malignant bone tumors around the knee joint were treated by joint-preserving intercalary resections with the aid of three-dimensional (3D)-printed osteotomy guide plates and reconstructions using 3D-printed intercalary prostheses. We assessed the accuracy of the resection by comparing the cross sections at the resection plane with 3D-printed matching surface of the prostheses. The functional outcomes, complications and oncological status were also evaluated. RESULTS: All patients were observed for 7 to 32 months with an average follow-up of 22.5 months. The achieved resection was accurate, with accurate matching between the residual bone and prosthesis. The mean MSTS score was 28 (range, 26-30). Superficial infection occurred in two patients. Local recurrence was observed in one patient, while pulmonary metastasis was identified in one patient. CONCLUSIONS: The personalized osteotomy guide plate and prosthesis based on 3D printing technique facilitate joint-preserving tumor resection and functional reconstruction. However, longer follow-up and larger sample size are required to clarify its long-term outcomes. LEVEL OF EVIDENCE: Level IV, therapeutic study.
38
A system for the surgical staging of musculoskeletal sarcoma.
Mark Goodman · PubMed · 1981 · 1K citations
Gaetano Bacci, Stefano Ferrari, Franco Bertoni et al. · Journal of Clinical Oncology · 2000 · 447 citations